438 related articles for article (PubMed ID: 30350771)
1. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
[TBL] [Abstract][Full Text] [Related]
3. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
4. Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Pal S; Myburgh J; Bansil P; Hann A; Robertson L; Gerth-Guyette E; Ambler G; Bizilj G; Kahn M; Zobrist S; Manis MR; Styke NA; Allan V; Ansbro R; Akingbade T; Bryan A; Murphy SC; Kublin JG; Layton M; Domingo GJ
PLoS One; 2021; 16(9):e0257560. PubMed ID: 34543346
[TBL] [Abstract][Full Text] [Related]
5. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
[TBL] [Abstract][Full Text] [Related]
6. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
[TBL] [Abstract][Full Text] [Related]
7. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
Bancone G; Chu CS; Chowwiwat N; Somsakchaicharoen R; Wilaisrisak P; Charunwatthana P; Bansil P; McGray S; Domingo GJ; Nosten FH
Am J Trop Med Hyg; 2015 Apr; 92(4):818-824. PubMed ID: 25646252
[TBL] [Abstract][Full Text] [Related]
8. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
[TBL] [Abstract][Full Text] [Related]
9. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
10. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
11. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
12. Repeatability and reproducibility of a handheld quantitative G6PD diagnostic.
Ley B; Winasti Satyagraha A; Kibria MG; Armstrong J; Bancone G; Bei AK; Bizilj G; Brito M; Ding XC; Domingo GJ; von Fricken ME; Gornsawun G; Lam B; Menard D; Monteiro W; Ongarello S; Pal S; Panggalo LV; Parikh S; Pfeffer DA; Price RN; da Silva Orfano A; Wade M; Wojnarski M; Worachet K; Yar A; Alam MS; Howes RE
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010174. PubMed ID: 35176015
[TBL] [Abstract][Full Text] [Related]
13. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
[TBL] [Abstract][Full Text] [Related]
14. Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
Gerth-Guyette E; Adissu W; Brito M; Garbin E; Macedo M; Sharma A; Das S; Lacerda MVG; Pereira D; Talukdar A; Yilma D; Pal S; Zobrist S; Domingo GJ
Malar J; 2021 Jul; 20(1):307. PubMed ID: 34238299
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis.
Adissu W; Brito M; Garbin E; Macedo M; Monteiro W; Mukherjee SK; Myburg J; Alam MS; Bancone G; Bansil P; Pal S; Sharma A; Zobrist S; Bryan A; Chu CS; Das S; Domingo GJ; Hann A; Kublin J; Lacerda MVG; Layton M; Ley B; Murphy SC; Nosten F; Pereira D; Price RN; Talukdar A; Yilma D; Gerth-Guyette E
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011652. PubMed ID: 37824592
[TBL] [Abstract][Full Text] [Related]
16. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
17. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
[TBL] [Abstract][Full Text] [Related]
18. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
19. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
Domingo GJ; Satyagraha AW; Anvikar A; Baird K; Bancone G; Bansil P; Carter N; Cheng Q; Culpepper J; Eziefula C; Fukuda M; Green J; Hwang J; Lacerda M; McGray S; Menard D; Nosten F; Nuchprayoon I; Oo NN; Bualombai P; Pumpradit W; Qian K; Recht J; Roca A; Satimai W; Sovannaroth S; Vestergaard LS; Von Seidlein L
Malar J; 2013 Nov; 12():391. PubMed ID: 24188096
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
